Concord Medical Services Holdings Limited
CCM · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $100 | $100 | $83 | $83 |
| % Growth | 0% | 21.5% | 0% | – |
| Cost of Goods Sold | $102 | $102 | $101 | $101 |
| Gross Profit | -$2 | -$2 | -$19 | -$19 |
| % Margin | -2.1% | -2.1% | -22.7% | -22.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $60 | $60 | $128 | $128 |
| SG&A Expenses | $70 | $70 | $148 | $148 |
| Sales & Mktg Exp. | $11 | $11 | $12 | $12 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $70 | $70 | $148 | $148 |
| Operating Income | -$72 | -$72 | -$167 | -$167 |
| % Margin | -72.1% | -72.1% | -202.5% | -202.5% |
| Other Income/Exp. Net | -$20 | -$20 | $1 | $1 |
| Pre-Tax Income | -$93 | -$93 | -$166 | -$166 |
| Tax Expense | $10 | $10 | $4 | $4 |
| Net Income | -$14 | -$14 | -$68 | -$68 |
| % Margin | -13.5% | -13.5% | -82.3% | -82.3% |
| EPS | -93.3 | -93.3 | -466.8 | -466.8 |
| % Growth | 0% | 80% | 0% | – |
| EPS Diluted | -94.5 | -94.5 | -468.9 | -468.9 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $42 | $42 | $58 | $58 |
| Depreciation & Amortization | $30 | $30 | $30 | $30 |
| EBITDA | -$42 | -$42 | -$137 | -$138 |
| % Margin | -41.9% | -41.9% | -165.8% | -166.5% |